Skip to main content
Sunday
May 05, 2024
Sign In
Subscribe
Home
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
বাংলা
SUNDAY,
MAY 05, 2024
remdesivir
Coronavirus chronicle
Gilead files US marketing application for remdesivir
Coronavirus chronicle
Canada gives conditional approval to Gilead's remdesivir for Covid-19
Pharma
Remdesivir saved the day for pharma industry
South Asia
Indian police arrest 14 for black market remdesivir as Covid-19 cases jump
Coronavirus chronicle
One in three South Korean Covid-19 patients improve with remdesivir
Coronavirus chronicle
Australia approves remdesivir as coronavirus treatment
Coronavirus chronicle
EU looking to ramp-up production of Covid-19 antiviral remdesivir
Coronavirus chronicle
EU grants conditional clearance to Covid-19 antiviral remdesivir
Coronavirus chronicle
US buys up world stock of key Covid-19 drug remdesivir
Coronavirus chronicle
Gilead prices Covid-19 drug candidate remdesivir at $2,340 per patient
Coronavirus chronicle
South Korea backs remdesivir for Covid-19, urges caution with dexamethasone
Coronavirus chronicle
Gilead's remdesivir set to become Europe's first Covid-19 therapy
Coronavirus chronicle
Gilead to test inhaled version of remdesivir on Covid-19 patients in August
Show More